Australia GLP-1 Receptor Agonist Market Growth Factors Increased adoption of GLP-1 receptor agonists: The safety and efficacy of GLP-1 receptor agonists for type 2 diabetes and obesity management is increasing the demand and adoption in the Australian population
Sourcing from the growers allows us to eliminate middleman markups and give you fresher ingredients at lower prices
Ideal for those struggling with weight management, these treatments provide a non-surgical solution to achieve your desired body weight, complemented by professional guidance and minimal downtime
Our team is always available to support you throughout your treatment process
Dawkins and Pratley note that while studies show people with obesity and type 2 diabetes experience significant weight loss on a GLP-1 agonist or dual agonist, people with type 2 diabetes experience slightly less weight loss compared with those with overweight and obesity without type 2 diabetes.1-3 Counseling Tips for RDs Despite the success of these classes of weight management medications, patients can receive anywhere from a little to a lot of information on how to optimize their use since a wide variety of clinicians, from primary care providers to obesity medicine experts, prescribe them
Not everyone reacts in the same way to GLP-1 injections
